Bangladesh vs India: Treatment success rate for patients treated for MDR-TB
Bangladesh
78.0%
in 2022
India
77.0%
in 2022
Bangladesh rank
59th
India rank
61st
Treatment success rate for patients treated for MDR-TB over time
- Bangladesh
- India
How they compare
Bangladesh currently reports 78.0% against 77.0% in India, a difference of 1.0%.
Across all 16 years both countries report, Bangladesh has been ahead every year.
Bangladesh ranks 59th and India ranks 61st of 163 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 48.7% | 27.3% | Bangladesh |
| 2010s | 74.1% | 49.2% | 24.9% | Bangladesh |
| 2020s | 76.0% | 73.0% | 3.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bangladesh or India?
- Bangladesh, at 78.0% against 77.0% in India as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bangladesh and India?
- 1.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and India?
- 16 years are reported by both, from 2007 to 2022.
- How do Bangladesh and India rank globally for treatment success rate for patients treated for mdr-tb?
- Bangladesh ranks 59th and India ranks 61st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.